Tower Research Capital LLC (TRC)
Position in IDXG — Interpace Biosciences, Inc.
CIK 1533421
NEW YORK, NY
Position in IDXG
as of Mar 31, 2021
· filed May 17, 2021
Position Value
$0
+$0 QoQ
Shares Held
35
-90.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXG Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $17,636,052 across 41 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
22,531 | $3,380,325 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
5,984 | $3,000,137 | |
| 3 | ILMN |
Illumina, Inc.
|
12,857 | $2,260,646 | |
| 4 | DHR |
Danaher Corp /De/
|
11,068 | $2,108,232 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
1,661 | $879,648 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
1,401 | $737,542 | |
| 7 | RVTY |
Revvity, Inc.
|
5,871 | $653,206 | |
| 8 | A |
Agilent Technologies, Inc.
|
4,814 | $639,443 |
All Filings in IDXG
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2021-03-31 | — | 177 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | — | 1,929 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | — | 1,404 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||